A director at Top Glove Corporation Bhd bought 2,000,000 shares at 0.672MYR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Adopting To A New Equilibrium Highlights Additional 100% US tariffs on China exports from the current high base have limited incremental impacts on Malaysian glovemakers’ earnings. Oversupply and sub-optimal utilisation rates are likely to continue to weigh on earnings recovery prospects. Sector’s risk-reward payoff appears neutral with potential structural de-rating from China’s capacity influx and aggressive expansion strategies. Maintain MARKET WEIGHT.
Greater China Economics | Trade China’s trade rebounded strongly in September, with exports (8.3%, +3.9ppt) and imports (7.4%, +6.1ppt) beating expectations. This month marked the strongest monthly growth for imports in 2025, thanks to the trade surplus narrowing to US$90.4b. Demand from non-US markets held firm while domestic recovery gained traction. Imports for integrated circuits, agricultural products and key commodities improved. On the export front, hi-tech and mechanical & electrical...
4QFY25: Improving Earnings Momentum, But Challenges Persist Highlights TOPG made a turnaround into core net profit in 4QFY25 due to strong volume sales and lower raw material costs. Despite better US demand and margin uptick anticipated in FY26, intensifying competition in Europe remains a threat to mid- to long-term earnings. Risk-reward appears neutral following yesterday’s share price action (+15%). Maintain HOLD with a lower target price of RM0.70 (from RM0.71).
Greater China Sector Update | Automobile This week we focus on China's automobile sector under the "anti-involution" policy, which is slowing auto sales and stabilising car prices, but pressuring margins. While domestic sales slow, exports remain strong. We maintain MARKET WEIGHT on China’s automobile sector, with CATL and Geely as our top BUYs for innovation, while advising investors to SELL BYD and Li Auto due to margin and sales pressures. Key focuses include policy execution, inventory and o...
Greater China Strategy | Alpha Picks: October Conviction Calls The HSI and MSCI China gained 7.1%/8.2% mom in September on Fed easing and optimism over advancements in semiconductors and AI. We remain positive in the medium term but expect near-term consolidation after the recent strong gains. The best performer of the month was Alibaba (+53.0% mom). With some rotations expected in non-tech stocks, our October calls are: add Galaxy, Jacobson, Ping An, Trip.com and WuXi Bio to BUY; SELL Meituan. ...
GREATER CHINA Strategy Alpha Picks: September Conviction Calls: Add Anta, BYDE and CSCEC to our BUY list, Li Auto and OOIL to our SELL list. Take profit on Innovent, JD Logistics, Lenovo, Sino Biopharm, Tencent and TME. INDONESIA Strategy Alpha Picks: Underperformance In August: Our new Alpha Picks are ASSA, ARCI, BBCA, BBNI, BRMS, MTEL, HRUM and NCKL. MALAYSIA Strategy Alpha Picks: Wake Me Up When September Ends: Our Aug 25 Alpha Picks underperformed marginally. Sep 25 picks: Alpha IVF, Hume ...
A Glimpse Of Hope Amid Trump Tariff Setback In a landmark decision, a US federal appeals court voted 7–4 to strike down most of President Trump’s global tariffs imposed under the International Emergency Economic Powers Act (IEEPA), ruling that the administration lacked explicit congressional authority. The verdict delivers a heavy blow to the cornerstone of Trump’s trade policy and marks its second consecutive defeat in the closely watched case of V.O.S. Selections vs Trump. Trump blasted the ru...
GREATER CHINA Strategy Alpha Picks: August Conviction Calls: Add JBM Healthcare and Lenovo to our BUY list. Take profit on CATL, Han’s Laser, KE Holdings and Longfor. INDONESIA Strategy Alpha Picks: Underperformance In July: Our new Alpha Picks are ASSA, AKRA, ARCI, BBNI, KLBF, MTEL, and MYOR. MALAYSIA Strategy Alpha Picks: Some Opportunities Amid A “Summer Lull”: Our July 25 Alpha Picks outperformed. Aug 25 picks: Coraza, Eco World, Gamuda, Hume Cement, IJM, Inari, RHB and Zetrix. SINGAPORE ...
Mounting Pressures From Elevated US Tariffs And China Competition The Malaysian glove sector is weathering challenges such as the geopolitical reshuffling, higher US reciprocal tariffs (25%), and intensifying competition from China. Earnings delivery is lagging expectations with a meaningful recovery expected only in 4Q25. Although the sector’s forward valuations are well below the historical average, we acknowledge that there could be a potential long-term structural de-rating. We lower our 202...
GREATER CHINA Sector Healthcare Bi-Weekly: Expecting strong 1H25 results. Maintain OVERWEIGHT. Results Contemporary Amperex Technology (300750 CH/BUY/Rmb277.09 /Target: Rmb390.00) 2Q25: Earnings in line, with margins hitting record-high levels. Maintain A-share at BUY. Downgrade H-share to HOLD. New Oriental Education & Technology Group (EDU US/BUY/US$44.37/Target: US$55.00) ...
GREATER CHINA Strategy Alpha Picks: July Conviction Calls: Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. INDONESIA Strategy Alpha Picks: Good Performances In June: Our new Alpha Picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA, AMRT and TLKM. MALAYSIA Strategy Alpha Picks: Positioning For Positive US Trade Deals: Our Jun 25 Alpha Picks outperform. Jul 25 picks: Coraza, Duopharma, Eco World, Gamuda, Hume Cement, IJM, Inari and MYEG. SINGAP...
3QFY25: Weathering Another Weak Quarter; Better Outlook Guidance TOPG turned into core losses in 3QFY25 due to a temporary weakness in US demand and intensifying competition in Europe. Nevertheless, management guided a 15-20% qoq volume sales growth in 4QFY25, reinforcing better demand and margin expansion on US distributors’ normalising inventory levels. Despite optimism over growth in the coming quarters, we lower our FY25-26 earnings forecasts and acknowledge the sector’s structural de-rating...
GREATER CHINA Strategy Property Weakening sales in China has raised hopes of policy support in July; rebound in HIBOR will test the strength of recovery in Hong Kong property sales. INDONESIA Update Bank Mandiri (BMRI IJ/BUY/Rp5,025/Target: Rp6,000) 5M25: Steady earnings amid NIM pressure. MALAYSIA Sector Oil & Gas ...
Cyclical Volatility From Episodic Narratives Amid geopolitical reshuffling, the US’ reciprocal tariffs, and intensifying China competitions, the Malaysian glove sector rode through a volatile 1H25. Despite the ytd steep share price correction reflecting mixed investor sentiments, we opine that riskreward remains attractive given the sector’s bargain forward valuations (-2SD below mean). 2H25 earnings will also see sequential improvement on better US replenishments. Maintain OVERWEIGHT.
GREATER CHINA Strategy Alpha Picks: June Conviction Calls: Add Prudential and Sino Biopharm to our BUY list. Take profit on SHKP and Trip.com. INDONESIA Strategy Alpha Picks: Good Performances In May: Good performances from most with the exception of GOTO and BUKA. MALAYSIA Strategy Alpha Picks: Raising Emphasis On Infrastructure Plays: Our May 25 Alpha Picks outperformed with resounding success. June 25 picks: Duopharma, Eco World, Gamuda, Hume Cement, IJM, MYEG, Northeast Group. SINGAPORE S...
Opportunities In A Ringgit Resurgence Environment The sharp ringgit appreciation driven by de-dollarisation and thus a broader reallocation of capital toward emerging market currencies support our view of a moderate upside for Malaysian equities. Key beneficiaries include importers and companies with high US dollar debt, while exporters may face margin pressure. While historical parallel suggests temporary trading opportunities, we recommend a tactical trading stance, focusing on value-driven op...
GREATER CHINA Strategy Alpha Picks: May Conviction Calls: Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. INDONESIA Strategy Alpha Picks: Outperformance In Apr 25: Remove ICBP, EXCL and MIKA; add BBTN and GOTO. MALAYSIA Strategy Alpha Picks: Capitalising On Sentiment Turnaround: Our Apr 25 Alpha Picks underperformed. May 25 picks: Duopharma, Gamuda, IJM, IOI Properties, TIME dotCom, MYEG, Nationgate, Northeast Group and RHB Bank. SINGAPO...
A Kaleidoscope Of Perceptions Underneath the facade of geopolitical reshuffling and the US’ reciprocal tariffs, the Malaysian glove sector faces mixed investor sentiments as uncertainty builds up. Nevertheless, the sector’s core fundamentals remain solid as we anticipate sequential earnings growth driven by a full recapturing of US market share. More importantly, ytd retracement and bargain forward valuations are offering an attractive risk-reward balance. Maintain OVERWEIGHT.
GREATER CHINA Sector Banking Playing safe amid tariff fears. Small/Mid Cap Highlights JBM Healthcare (2161 HK/BUY/HK$1.75/Target: HK$2.42) FY26: New rounds of marketing campaigns to fuel growth. INDONESIA Results Merdeka Copper Gold (MDKA IJ/BUY/Rp1,040/Target: Rp1,900) FY24: Below our and street’s expectations MALAYSIA Sector Gloves ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.